Robert Gerber is a seasoned professional with 25 years of experience in the pharmaceutical industry, currently leading the Inflammation & Immunology Value & Evidence Team at Pfizer. They have previously held positions such as Senior Director of Health Economics and Outcomes Research, contributing to diverse therapeutic areas and supporting significant market access initiatives. Robert has authored over 100 publications and abstracts and holds advanced degrees in clinical pharmacy, economics, and business from prestigious institutions including the University of Southern California and London Business School. Prior to their career in pharmaceuticals, Robert worked as a Clinical Pharmacist involved in formulary decisions and clinical therapeutics in managed care settings.
This person is not in any teams
This person is not in any offices